Press Release February 26, 2022SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bumble Inc. - BMBL 0 0 Share
Press Release February 26, 2022ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Bumble Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - BMBL 0 0 Share
Press Release February 25, 2022Century Communities' Multifamily Division Breaks Ground in Lone Tree, CO on Mixed-Use Apartment Complex 0 0 Share
Press Release February 25, 2022AES Announces Intent to Exit Coal by 2025; Reaffirms 7% to 9% Annualized Growth Target Through 2025; Delivers on All 2021 Financial and Strategic Objectives 0 0 Share
Press Release February 25, 2022STMicroelectronics Publishes its 2021 Annual Report Form 20-F 0 0 Share
Press Release February 25, 2022JD.com and Dada Announce Progress Update on Investment in Dada 0 0 Share
Press Release February 25, 2022Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for Opdivo (nivolumab) as Adjuvant Treatment for Patients with Radically Resected, High-Risk Muscle-Invasive Urothelial Carcinoma with Tumor Cell PD-L1 Expression ≥1% 0 0 Share
Press Release February 25, 2022Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for Opdivo (nivolumab) plus Yervoy (ipilimumab) for First-Line Treatment of Patients with Unresectable Advanced, Recurrent or Metastatic Esophageal Squamous Cell Carcinoma. 0 0 Share
